Samsara BioCapital, LLC
data from 31/03/2026
Capitalization
Portfolio size
Portfolio performance
Portfolio performance %
Performance compared to S&P 500 (%)
Stock in Samsara BioCapital, LLC
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2026/03/31 | SRRK | SCHOLAR ROCK HLDG CORP | 32.95% | 339.089 M $ | 6897652 | 2022/03/31 | 35.247 M $ | 11.60 % |
| 2026/03/31 | MLYS | MINERALYS THERAPEUTICS INC | 15.45% | 159.046 M $ | 5871018 | 2023/03/31 | -54.013 M $ | -25.35 % |
| 2026/03/31 | ALMS | ALUMIS INC | 13.58% | 139.785 M $ | 6345219 | 2024/09/30 | 70.638 M $ | 125.72 % |
| 2026/03/31 | SEPN | SEPTERNA INC | 7.35% | 75.674 M $ | 3149128 | 2024/12/31 | -12.124 M $ | -13.81 % |
| 2026/03/31 | KLRS | KALARIS THERAPEUTICS INC | 7.26% | 74.710 M $ | 12948081 | 2025/03/31 | -34.571 M $ | -31.64 % |
| 2026/03/31 | SGP | SPYGLASS PHARMA INC | 5.31% | 54.669 M $ | 2109953 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | NGNE | NEUROGENE INC | 3.36% | 34.617 M $ | 1717127 | 2023/12/31 | -755.535 K $ | -2.14 % |
| 2026/03/31 | IVA | INVENTIVA SA | 2.80% | 28.831 M $ | 5194805 | 2025/12/31 | 4.675 M $ | 19.35 % |
| 2026/03/31 | STRO | SUTRO BIOPHARMA INC | 2.57% | 26.476 M $ | 1062872 | 2025/12/31 | 2.728 M $ | 115.30 % |
| 2026/03/31 | JBIO | JADE BIOSCIENCES INC | 1.32% | 13.612 M $ | 968798 | 2025/06/30 | -1.337 M $ | -8.94 % |
| 2026/03/31 | VTVT | VTV THERAPEUTICS INC | 1.15% | 11.838 M $ | 298496 | 2023/12/31 | -98.503 K $ | -0.83 % |
| 2026/03/31 | AQST | AQUESTIVE THERAPEUTICS INC | 1.01% | 10.375 M $ | 2500000 | 2025/09/30 | -5.775 M $ | -35.76 % |
| 2026/03/31 | XFOR | X4 PHARMACEUTICALS INC | 0.74% | 7.568 M $ | 1832566 | 2025/12/31 | 254.799 K $ | 3.25 % |
| 2026/03/31 | NKTX | NKARTA INC | 0.72% | 7.401 M $ | 3507666 | 2020/09/30 | 911.993 K $ | 14.05 % |
| 2026/03/31 | ACLX | ARCELLX INC | 0.68% | 6.989 M $ | 60873 | 2022/03/31 | 3.021 M $ | 76.10 % |
| 2026/03/31 | UPB | UPSTREAM BIO INC | 0.64% | 6.624 M $ | 736047 | 2024/12/31 | -13.359 M $ | -66.85 % |
| 2026/03/31 | ABVX | ABIVAX SA | 0.61% | 6.300 M $ | 56581 | 2023/12/31 | -1.773 M $ | -17.43 % |
| 2026/03/31 | AGMB | AGOMAB THERAPEUTICS NV | 0.61% | 6.294 M $ | 600000 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | RANI | RANI THERAPEUTICS HLDGS INC | 0.61% | 6.246 M $ | 8500000 | 2025/12/31 | -5.229 M $ | -45.57 % |
| 2026/03/31 | CHRS | COHERUS ONCOLOGY INC | 0.56% | 5.794 M $ | 3428571 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | PVLA | PALVELLA THERAPEUTICS INC NE | 0.47% | 4.791 M $ | 38432 | 2024/12/31 | 2.094 M $ | 19.09 % |
| 2026/03/31 | GOSS | GOSSAMER BIO INC | 0.23% | 2.373 M $ | 7222559 | 2023/09/30 | -20.017 M $ | -89.40 % |
| 2026/03/31 | CTNM | CONTINEUM THERAPEUTICS INC | 0.00% | 0.000 $ | 0 | 2024/06/30 | 0.000 $ | 0.00 % |
| 2026/03/31 | NUVB-WT | NUVATION BIO INC | 0.00% | 0.000 $ | 0 | 2022/06/30 | 0.000 $ | 0.00 % |